Gershenson DM, Cobb LP, Westin SN, Zhang Y, et al. Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival. Gynecol Oncol 2022 Sep 19. pii: S0090-8258(22)00591.
PMID: 36137845